| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.31 | 7e-16 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-15 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-14 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-14 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-14 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-13 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-12 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-12 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-11 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.34 | 2e-11 |